The Future of the U.S. Oncology Market: Preparing for Healthcare 2.0
Apr 7, 2015
This 15-page report presents cross-industry analysis on reimbursement and market access strategies designed to help you:
- Overcome barriers to traditional premium pricing
- Re-align stakeholder partnerships in the context of evidence-based care and clinical pathways
- Leverage risk-sharing agreements as a mechanism of market access in the US
- Achieve favorable reimbursement through ECV differentiation and value added services
- Prepare for demands around companion diagnostics
Please subscribe to view the analysis report